MR Grever
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 11
- Hematology top 5%
- Acute Myeloid Leukemia Research 3
- Physiology top 5%
- Immunology top 10%
- T-cell and Retrovirus Studies 3
- Immune Cell Function and Interaction 2
-
- Acute Lymphoblastic Leukemia research 5
-
- HIV/AIDS drug development and treatment 4
-
- Biochemical and Molecular Research 3
-
- Renal Transplantation Outcomes and Treatments 2
- Co-authors
- Balcerzak SpLouis MalspeisJJ HuttonDeborah YoungKJ KopeckyFR AppelbaumIM ChenJonathan D. Licht
- Journals
- Blood (13 papers)PubMed (11 papers)
- Partner nations
- United StatesIndia
In The Last Decade
MR Grever
23 papers receiving 800 citations
Peers
Comparison fields: 5 of 63
- Genetics 389
- Hematology 188
- Pathology and Forensic Medicine 292
- Physiology 69
- Immunology 242
Countries citing papers authored by MR Grever
This map shows the geographic impact of MR Grever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MR Grever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MR Grever more than expected).
Fields of papers citing papers by MR Grever
This network shows the impact of papers produced by MR Grever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MR Grever. The network helps show where MR Grever may publish in the future.
Co-authorship network
The 17 scholars most cited alongside MR Grever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytotoxic alkaloids from Tylophora indica. | 2001 | 11 |
| 2 | Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders. | 2000 | 1 |
| 3 | Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals. | 1998 | 50 |
| 4 | 1994 | 71 | |
| 5 | 1994 | 161 | |
| 6 | 1994 | 1 | |
| 7 | Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate. | 1990 | 88 |
| 8 | 1988 | 3 | |
| 9 | Treatment of patients with acute nonlymphocytic leukemia not in remission. | 1987 | 11 |
| 10 | Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycin. | 1987 | 15 |
| 11 | Phase I trial of teroxirone. | 1984 | 3 |
| 12 | 1983 | 82 | |
| 13 | 1983 | 0 | |
| 14 | 1983 | 4 | |
| 15 | 1983 | 23 | |
| 16 | Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia. | 1982 | 5 |
| 17 | 2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia. | 1982 | 6 |
| 18 | 1981 | 180 | |
| 19 | 1981 | 6 | |
| 20 | 1980 | 22 |
About MR Grever
MR Grever is a scholar working on Genetics, Physiology and Transplantation, having authored 24 papers that have together received 848 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (5 papers), HIV/AIDS drug development and treatment (4 papers), Acute Myeloid Leukemia Research (3 papers), T-cell and Retrovirus Studies (3 papers), Biochemical and Molecular Research (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Genetics (389 citations), Hematology (188 citations) and Pathology and Forensic Medicine (292 citations). MR Grever has collaborated with scholars based in United States and India. Frequent co-authors include Balcerzak Sp, Louis Malspeis, JJ Hutton, Deborah Young, KJ Kopecky, FR Appelbaum, IM Chen, Jonathan D. Licht, Coltman Ca and David Head. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.